Drugs / Anshen Buxin Liuwei Pill
Anshen Buxin Liuwei Pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04932395 | Jun 2021 → Dec 2023 | neurocirculatory asthenia | China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anshen Buxin Liuwei Pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04932395 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional Mongolian medicine Anshen Buxin Liuwei Pill” NCT04932395 ↗ |
| Route | Oral | “15 capsules/time, 2 times/day, orally” NCT04932395 ↗ |